Evidence map›Paper›PMID 30957420›Full record

ArticleJournal of the International AIDS Society2019

Implementation of a comprehensive safer conception intervention for HIV-serodiscordant couples in Kenya: uptake, use and effectiveness.

Renee Heffron, Kenneth Ngure, Jennifer Velloza, Catherine Kiptinness, Justice Quame-Amalgo, Lynda Oluch, Nicholas Thuo, John Njoroge, Richard Momanyi, Stephen Gakuo and 7 more

Abstract readEvaluation Study
In one paragraph

Article in Journal of the International AIDS Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. "Sexual and reproductive health matters · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Renee HeffronDepartment of Global Health, University of Washington, Seattle, WA, USA.ORCID 0000-0001-6039-0352
Kenneth NgureDepartment of Global Health, University of Washington, Seattle, WA, USA.
Jennifer VellozaDepartment of Global Health, University of Washington, Seattle, WA, USA.
Catherine KiptinnessPartners in Health and Research Development, Centre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya.
Justice Quame-AmalgoDepartment of Global Health, University of Washington, Seattle, WA, USA.
Lynda OluchPartners in Health and Research Development, Centre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya.
Nicholas ThuoPartners in Health and Research Development, Centre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya.
John NjorogePartners in Health and Research Development, Centre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya.
Richard MomanyiPartners in Health and Research Development, Centre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya.
Stephen GakuoPartners in Health and Research Development, Centre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya.
Sarah MbuguaPartners in Health and Research Development, Centre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya.
Susan MorrisonDepartment of Global Health, University of Washington, Seattle, WA, USA.
Harald HaugenDepartment of Global Health, University of Washington, Seattle, WA, USA.
Bhavna ChohanDepartment of Global Health, University of Washington, Seattle, WA, USA.
Connie CelumDepartment of Global Health, University of Washington, Seattle, WA, USA.ORCID 0000-0002-8813-3419
Jared M BaetenDepartment of Global Health, University of Washington, Seattle, WA, USA.ORCID 0000-0001-8242-8438
Nelly MugoDepartment of Global Health, University of Washington, Seattle, WA, USA.

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI EDWIN ROBERTO ORELLANA · 1988 to 2026
$104.9M
Antiretroviral periconception HIV prevention for HIV discordant couplesR00HD076679 · NICHD · UNIVERSITY OF WASHINGTON · PI HEFFRON, RENEE A. · 2015 to 2017
$742k
Enhancing safer conception for HIV serodiscordant couples through mobile technologiesR21TW009908 · FIC · UNIVERSITY OF WASHINGTON · PI HEFFRON, RENEE A. · 2014 to 2015
$349k
Depression and Pre-Exposure Prophylaxis Use among sub-Saharan African WomenF31MH113420 · NIMH · UNIVERSITY OF WASHINGTON · PI VELLOZA, JENNIFER · 2017 to 2018
$84k
FIC NIH HHS R21 TW009908NIAID NIH HHS P30 AI027757NICHD NIH HHS R00 HD076679NIMH NIH HHS F31 MH113420
6 · The paper itself

Abstract

introductionSafer conception strategies minimize HIV risk during condomless sex to become pregnant. Gaps remain in understanding the acceptability, feasibility and choices HIV-serodiscordant couples make when multiple safer conception options are available.

methodsWe conducted a pilot study of a comprehensive safer conception package for HIV-serodiscordant couples with immediate fertility desires in Kenya from March 2016 to April 2018. The intervention package included antiretroviral therapy (ART) for HIV-positive partners, oral pre-exposure prophylaxis (PrEP) for HIV-negative partners, daily fertility and sexual behaviour tracking via short message service (SMS) surveys, counselling on self-insemination, and referrals for voluntary medical male circumcision and fertility care. Couples attended monthly visits until pregnancy with HIV testing for negative partners at each visit. We estimated the number of expected HIV seroconversions using a counterfactual cohort simulated from gender-matched couples in the placebo arm of a previous PrEP clinical trial. We used bootstrap methods to compare expected and observed seroconversions.

resultsOf the 74 enrolled couples, 54% were HIV-negative female/HIV-positive male couples. The 6 and 12-month cumulative pregnancy rates were 45.3% and 61.9% respectively. In the month preceding pregnancy, 80.9% of HIV-positive partners were virally suppressed, 81.4% of HIV-negative partners were highly adherent to PrEP, and SMS surveys indicated potential timing of condomless sex to peak fertility (median of sex acts = 10, interquartile range (IQR) 7 to 12; median condomless sex acts = 3.5, IQR 1 to 7). Most (95.7%) pregnancies were protected by ≥2 strategies: 57.4% were protected by high PrEP and ART adherence, male circumcision with or without timed condomless sex; 10 (21.3%) were protected by viral suppression in the HIV-positive partner and male circumcision with or without timed condomless sex; 8 (17.0%) were protected by high PrEP adherence and male circumcision with or without timed condomless sex. We observed 0 HIV seroconversions (95% CI 0.0 to 6.0 per 100 person years), indicating a 100% reduction in HIV risk (p = 0.04).

conclusionsThe use of multiple safer conception strategies, primarily PrEP, ART, male circumcision and/or tracking fertility, was acceptable and feasible for African HIV-serodiscordant couples and significantly reduced HIV transmission risk. It is important to increase the availability of and counselling about safer conception services in regions with HIV epidemics involving heterosexual transmission and high fertility.

Indexed as

FertilizationAdultAnti-HIV AgentsCounselingFemaleFertilityHIV InfectionsHumansKenyaMaleMiddle AgedPilot ProjectsPre-Exposure ProphylaxisPregnancySafe SexSexual BehaviorAnti-HIV AgentsARTfertilityHIV-serodiscordant couplespregnancyPrEPsafer conception

Identifiers

PMID30957420
PMCPMC6452026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.